MicroPort CardioFlow Medtech Corporation

SEHK:2160 Rapporto sulle azioni

Cap. di mercato: HK$1.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MicroPort CardioFlow Medtech Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jeffrey R Lindstrom

Amministratore delegato

CN¥4.0m

Compenso totale

Percentuale dello stipendio del CEO59.8%
Mandato del CEO1.1yrs
Proprietà del CEOn/a
Durata media del management3.9yrs
Durata media del Consiglio di amministrazione3.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?

Aug 07
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?

Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding

Jun 19
Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding

MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

May 29
MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

Apr 05
MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

Feb 23
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued

Jan 18
An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued

Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth

Oct 04
Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth

Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%

May 31
Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

May 23
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts

Apr 06
The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts

MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

Feb 08
MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

Oct 18
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate

Jun 30
We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate

Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts

Apr 04
Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts

MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Apr 03
MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued

Jan 21
An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued

Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?

Sep 05
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?

We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn

Jun 07
We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn

Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)

May 03
Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jeffrey R Lindstrom rispetto agli utili di MicroPort CardioFlow Medtech?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-CN¥349m

Mar 31 2024n/an/a

-CN¥410m

Dec 31 2023CN¥4mCN¥2m

-CN¥472m

Compensazione vs Mercato: La retribuzione totale di Jeffrey R ($USD 561.58K ) è superiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 371.52K ).

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Jeffrey R con le performance aziendali.


AMMINISTRATORE DELEGATO

Jeffrey R Lindstrom (57 yo)

1.1yrs

Mandato

CN¥4,004,000

Compensazione

Mr. Jeffrey R Lindstrom is President, Executive Director & General Manager of MicroPort CardioFlow Medtech Corporation from August 29, 2023. He served as senior director of engineering in Edwards Lifescien...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Jeffrey R Lindstrom
President1.1yrsCN¥4.00mNessun dato
Liang Zhao
Executive Director & First VP of Total Solutions2.3yrsCN¥3.91m0.058%
CN¥ 916.6k
Luying Yan
VP & Executive Director4yrsCN¥2.70m0.042%
CN¥ 658.0k
Xiangmei Li
Joint Company Secretary3.9yrsNessun datoNessun dato
Lok Yee Chan
Joint Company Secretary3.9yrsNessun datoNessun dato

3.9yrs

Durata media

43yo

Età media

Gestione esperta: Il team dirigenziale di 2160 è considerato esperto (durata media dell'incarico 3.8 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Jeffrey R Lindstrom
President1.1yrsCN¥4.00mNessun dato
Liang Zhao
Executive Director & First VP of Total Solutions2.3yrsCN¥3.91m0.058%
CN¥ 916.6k
Luying Yan
VP & Executive Director4yrsCN¥2.70m0.042%
CN¥ 658.0k
Jonathan H. Chou
Independent Non-Executive Director3.7yrsCN¥254.00kNessun dato
Xia Wu
Non-Executive Director5.1yrsNessun datoNessun dato
Guoming Chen
Non-Executive Chairman of the Board4yrsCN¥3.16m0.031%
CN¥ 482.8k
Junjie Zhang
Non-Executive Director5.1yrsNessun datoNessun dato
Zhixiang Sun
Independent Non-Executive Director3.7yrsCN¥254.00kNessun dato
Jiandong Ding
Independent Non-Executive Director3.1yrsCN¥254.00k0.0012%
CN¥ 19.4k

3.7yrs

Durata media

47yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 2160 sono considerati esperti (durata media dell'incarico 3.6 anni).